Zydus receives USFDA's nod for Dutasteride and Tamsulosin Hydrochloride Capsules

25 May 2018 Evaluate

Zydus Cadila has received the final approval from the US Food and Drug Administration (USFDA) to market Dutasteride and Tamsulosin Hydrochloride Capsules, 0.5 mg/0.4 mg. The drug is used to treat symptoms of Benign Prostatic Hyperplasia (BPH). It will be manufactured at the group's manufacturing facility at Moraiya, Ahmedabad.

The group now has more than 190 approvals and has so far filed over 320 ANDAs since the commencement of the filing process in FY 2003-04.

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies

Zydus Lifesciences Share Price

1096.45 12.25 (1.13%)
12-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.75
Dr. Reddys Lab 6045.00
Cipla 1540.70
Zydus Lifesciences 1096.45
Lupin 1607.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.